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Agingα-Crystallin is a major protein in the human lens that is perceived to help to maintain the transparency of the lens
through its chaperone function. In this study, we demonstrate that many lens proteins including αA-crystallin are
acetylated in vivo. We found that K70 and K99 in αA-crystallin and, K92 and K166 in αB-crystallin are acet-
ylated in the human lens. To determine the effect of acetylation on the chaperone function and structural
changes, αA-crystallin was acetylated using acetic anhydride. The resulting protein showed strong immu-
noreactivity against a Nε-acetyllysine antibody, which was directly related to the degree of acetylation. When
compared to the unmodiﬁed protein, the chaperone function of the in vitro acetylated αA-crystallin was higher
against three of the four different client proteins tested. Because a lysine (residue 70; K70) in αA-crystallin is
acetylated in vivo, we generated a protein with an acetylation mimic, replacing Lys70 with glutamine (K70Q).
The K70Q mutant protein showed increased chaperone function against three client proteins compared to the
Wt protein but decreased chaperone function against γ-crystallin. The acetylated protein displayed higher sur-
face hydrophobicity and tryptophan ﬂuorescence, had altered secondary and tertiary structures and displayed
decreased thermodynamic stability. Together, our data suggest that acetylation of αA-crystallin occurs in the
human lens and that it affects the chaperone function of the protein.
© 2011 Elsevier B.V. All rights reserved.1. Introduction
The acetylation and deacetylation of histones in the cell nucleus
regulates gene expression [1–3]. Recent studies show that a large
number of cytosolic proteins are acetylated, suggesting an important
role for acetylation in the function of cellular proteins [4–7]. The acety-
lation of lysine residues is mediated by lysine acetyltransferases (for-
merly called histone acetyltransferases), which transfer the acetyl
group from acetyl-CoA to the epsilon amino group of lysine residues
in proteins [8]. The reverse reaction is catalyzed by protein deacetylases,
which include NAD-dependent sirtuins (SIRT) [9]. Although there are
no reported studies on lysine acetyltransferases in the human lens, a0.05% Tween-20; NFDM, non-
ter-soluble lens protein; SWI,
hydride; TNS, 6-(p-toluidinyl)
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ology and Visual Sciences, Pa-
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l rights reserved.recent study showed that the expression of SIRT1 is increased in age-
related cataracts in humans and suggested that SIRT1 might protect
lens epithelial cells against apoptosis [10].
The human lens contains high concentrations of proteins, up to
400 mg/ml. The tight orderly packing of lens proteins, known as crys-
tallins, gives the lens the required transparency to focus images onto
the retina. Among lens crystallins, α-crystallin is a major type. It is
made up of two subunits, αA and αB-crystallin, with 60% sequence
homology between the subunits. Both subunits can function as mo-
lecular chaperones [11]. They inhibit the aggregation of unfolded pro-
teins to limit their denaturation, in an ATP-independent manner. It is
widely believed that the chaperone function of α-crystallin plays a
critical role in maintaining lens transparency during aging. Mutations
of α-crystallin that reduce its chaperone function have been known
to result in cataract formation, emphasizing the importance of the
chaperone function for lens transparency [12–15].
α-Crystallin is also a robust anti-apoptotic protein. It inhibits apopto-
sis of cells through a number of apoptotic stimuli: by binding to
procaspase-3, binding to Bax, inhibiting cytochrome-C release from
the mitochondria, by activating PI3 kinase, promoting the activation of
PDK-1 and AKT and inhibiting PTEN [16–19]. For some of these func-
tions, the chaperone function appears to be necessary.
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important role in tissue homeostasis. For example, in retinal pigment
epithelial cells, it prevents oxidative stress-induced apoptosis [20]. In
breast cancer cells, it promotes proliferation [21]. In retinal angiogene-
sis, it helps proper folding and secretion of VEGF-A [22].
Crystallin acetylation occurs in the lens. There are several reports
on N-terminal acetylation [23–25]; however, reports on acetylation
at lysine residues are sparse [26–28]. Other studies have shown that
lysine residues in α-crystallin can be readily acetylated and acetyla-
tion leads to alteration in protein structure [29,30]. Previous studies
have also shown that treatment with aspirin acetylates lens proteins
and inhibits glycation in vivo and in vitro [31,32]. One report indicates
that up to 5% of αA-crystallin in the human lens is acetylated at K70
[26]. K70 lies in the crystallin-core domain, and it is one of the iden-
tiﬁed sites for the chaperone function. Furthermore, one of the
“mini-chaperones” of α-crystallin identiﬁed in Sharma's laboratory
resides in close proximity to the K70 residue [33], which could have
an impact on the chaperone function. Considering that the chaperone
and anti-apoptotic functions are directly related, it is likely that in
vivo acetylation of αA-crystallin would have effects on both functions.
In this study, we have investigated the effects on the chaperone func-
tion through the in vitro acetylation of αA-crystallin and by using an
acetylation mimic of αA-crystallin.
2. Methods
Dithiothreitol (DTT), bovine insulin, citrate synthase (CS), acetic an-
hydride and lysozyme were obtained from Sigma-Aldrich Chemical Co.
LLC (St. Louis, MO, USA). CS was dialyzed against 40 mMHEPES buffer,
pH 7.4, for 24 h before use. 2-(p-toluidinyl) naphthalene-6-sulfonate
(TNS) was obtained from Molecular Probes (Invitrogen, Carlsbad, CA,
USA). Bovine γ-crystallin was puriﬁed from calf lenses as previously
described [34]. All other chemicals were of analytical grade.
2.1. Identiﬁcation of Nε-acetyllysine in α-crystallin of the human lens
This study adhered to the tenets of the Declaration of Helsinki.
Water-soluble protein from a 59-year old lens (isolated as described
below) at 1.0 mg in 200 μl of cell lysis buffer (Cell Signaling Technolo-
gies, Danvers, MA) was pre-cleaned by treating with 25 μl of Protein
A/G Sepharose (Thermo Scientiﬁc) for 30 min at 4 °C. The suspension
was centrifuged at 3000 g for 2 min. To the supernatant, 24 μl of a
monoclonal antibody against Nε-acetyllysine (Cell Signaling Technolo-
gies, Danvers,MA)was added and incubated for 2 h at 37 °C. To this sus-
pension, 20 μl of ProteinA/G Sepharose was added and incubated for
16 h at 4 °C. The gel suspension was then centrifuged at 1000 g for
2 min and the gel was separated. The gel was then washed three
times with ice-cold cell lysis buffer by centrifugation as above. The
washed gel was incubated for 5 min at 95 °C in the sample buffer and
subjected SDS-PAGE on a 12% gel. Gel bands between 20 and 25 kDa
were excised from the gel and were ﬁst destained with 50% acetonitrile
in 100 mM ammonium bicarbonate, and 100% acetonitrile. Then, the
protein was reduced by 20 mM DTT at room temperature for 60 min
followed by the alkylation using 50 mM idoacetamide for 30 min in
the dark. The reaction reagents were removed and the gel pieces were
washed with 100 mM ammonium bicarbonate and dehydrated in ace-
tonitrile. Sequencing grade modiﬁed trypsin (Promega, Madison, WI)
in 50 mM ammonium bicarbonate was added to the dried gel pieces
and incubated at 37 °C for overnight. Proteolytic peptides extracted
from the gel with 50% acetonitrile in 5% formic acid were then dried
and dissolved in 0.1% formic acid. Liquid chromatography–tandem
mass spectrometry analysis of the resulting peptides was performed
on a LTQ Orbitrap XL linear ion trap mass spectrometer (Thermo Fisher
Scientiﬁc,Waltham,MA) equippedwith an Ultimate 3000HPLC system
(Dionex, Sunnyvale, CA). The spectra were acquired by data dependent
methods consisting of a full scan andMS/MS on the ﬁvemost abundantprecursor ions at the normalized collision energy of 30%. The obtained
data were submitted to Mascot Daemon (Matrix Science, Boston, MA)
by searching the acetylation on Lys residues. The modiﬁcation sites
were then veriﬁed by manual interpretation of the obtained MS/MS
spectra.
2.2. Detection of Nε-acetyllysine in human lens proteins by ELISA
Human lenses were obtained from Heartland Lions Eye Bank, Co-
lumbia, MO. Lenses were stored at −80 °C until use. Each lens was
decapsulated and homogenized in 1.0 ml of PBS containing 0.2 mM
EDTA (PBS-EDTA) and centrifuged at 20,000×g for 30 min. The resulting
supernatant was separated from the pellet. A volume of 0.5 ml of the
above buffer was added to the pellet, which was re-suspended and cen-
trifuged as before. The two supernatant fractionswere pooled and desig-
nated the water-soluble fraction (WS). The pellet was subjected to
sonication (amplitude=30%, three 40 second cycles) in 1.0 ml PBS-
EDTA. The sonicated sample was centrifuged at 20,000×g for 30 min.
The resulting supernatant fraction was designated as the sonicated
water insoluble (SWI) fraction. Unless otherwise mentioned, protein
concentrations in samples were determined using the BCA Protein
Assay Kit (Thermo Scientiﬁc, Rockford, IL) and BSA as the standard.
Microplate wells were coated with 5 μg protein/well of the WS
and SWI fractions in 50 μl of 50 mM sodium carbonate buffer, pH
9.6, overnight at 4 °C followed by washing three times with PBST.
The wells were blocked with 5% non-fat dry milk (NFDM) in PBST
for 2 h. Following washing, a 1:5000 diluted mouse monoclonal anti-
body (in PBST-NFDM) against Nε-acetyllysine was added and incu-
bated for 1 h at 37 °C. The wells were then washed three times with
PBST and incubated with 1:5000-diluted goat anti-mouse antibody
conjugated to horseradish peroxidase (Promega, Madison, WI). Fol-
lowing incubation for 1 h and washing three times with PBST, the
wells were incubated with 100 μl of 3,3′,5,5′-tetramethylbenzidine
dihydrochloride (Sigma-Aldrich) substrate for 45 min at 37 °C. The
enzymatic reaction was stopped at 45 min by the addition of 50 μl
of 2 N H2SO4, and the optical density of the wells was read at
450 nm in a microplate reader.
2.3. Cloning and puriﬁcation of wild-type (Wt) and a K70Q mutant of
human αA-crystallin
Wild type αA-crystallin was ampliﬁed using the following for-
ward and reverse primers:
F: 5-GGCCATATGGACGTGACCATCCAGCAC
R: 3-CCCAAGCTTGGACGAGGGAGCCGAGGTG
The ampliﬁed PCR product was cloned into pET23a vector using
Nde I and HindII restriction sites. To generate the K70Q mutant pro-
tein, αA-crystallin in a pET23a (+) vector was ampliﬁed with the for-
ward primer 5′-GAC CGG GAC CAA TTC GTC ATC-3′ and a
complementary reverse primer. The resulting PCR product was
digestedwith DpnI and transformed into E. coliDH5alpha cells. Plasmids
from the resulting colonies were sequenced to conﬁrm the presence of
the mutation. This plasmid was then transformed into E. coli BL21
(DE3) cells for protein puriﬁcation.
When the culture reached its target density of OD ~0.6 (OD600 nm),
the recombinant proteins were overexpressed in E. coli BL21(DE3)
cells by induction with 250 μM IPTG. The bacterial pellet obtained
after centrifugation at 5000×g was suspended in 50 mM Tris, pH
8.0, containing 50 mM NaCl, 2 mM EDTA and 10 μl/ml of a protease
inhibitor cocktail (Sigma, Cat# P8849). Lysozyme was added to the
cell suspension at 0.3 mg/ml and incubated for 10 min at 37 °C fol-
lowed by sonication on ice at 30% amplitude and duty cycle=40. To
the resulting cell lysate, 1.0 μl of benzonase nuclease (Sigma-Aldrich,
Cat# E1014) was then added and incubated at 37 °C in a shaker for
Table 1
Identiﬁcation Nε-acetyllysine human lens α-crystallin.
Proteins Peptides Acetyl
site
Obs.
mass
Cal.
mass
Mass error
(ppm)
αB-crystallin VKVLGDVIEVHGK K92 1433.8262 1433.8242 1
EEKPAVTAAPK K166 1181.6314 1181.6292 2
αA-crystallin SDRDKFVIFLDVK K70 1622.8711 1622.8668 3
DKFVIFLDVK K70 1264.7096 1264.7067 2
VQDDFVEIHGKHNER K99 1863.8860 1863.8864 0
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at 1.0 mg/ml and another incubation for 10 min at 37 °C. DTT was
then added to the lysate at a 5 mM concentration and incubated for
10 min at 37 °C. The cell lysate was centrifuged at 20,000×g for
30 min at 4 °C. DNA in the lysate was precipitated by adding 0.2%
polyethyleneimine followed by centrifugation at 20,000×g for
15 min. Ammonium sulfate was added to the lysate to reach 70% satu-
ration; the protein solution was then left at 4 °C overnight and centri-
fuged at 20,000×g for 5 min. The resulting pellet was suspended in
50 mM sodium phosphate buffer, pH 7.4, containing 150 mM NaCl
and 5 mMDTT, and itwas centrifuged at 20,000×g for 5 min. The super-
natant was ﬁltered through a 0.45-μm ﬁlter and loaded onto a
Superdex-200 prep-grade gel ﬁltration column (GE Healthcare, WI)
that was pre-equilibrated with 50 mM sodium phosphate buffer, pH
7.4, containing 5 mM DTT. Fractions of 3.0 ml were collected, and their
OD280 nm was recorded. The protein peak fractions were pooled and
dialyzed overnight at 4 °C against 20 mM Tris, pH 8.0, containing
0.1 mM EDTA. The dialyzed sample was applied onto a Q-Sepharose
anion exchange column (GE Healthcare, NJ), equilibrated with
20 mM Tris, pH 8.0, containing 0.1 mM EDTA. The bound protein
was eluted with a 0–1 M NaCl gradient in the same buffer. The pro-
tein peak fractions were pooled and dialyzed against PBS containing
0.1 mM EDTA.2.4. Acetylation of αA-crystallin
Acetic anhydride (Ac2O) in dioxane was added to 550 μg of αA-
crystallin in 150 μl of PBS drop-wise over a period of 1 h to obtain ly-
sine (in αA-crystallin) to Ac2O molar ratios of 1:0, 1:2, 1:5, 1:10, 1:25
and 1:100 (pH was maintained at 7.4 with diluted NH4OH). The vol-
ume of the reaction mixture was adjusted to 500 μl with PBS and di-
alyzed overnight against 1 L of PBS.2.5. Mass spectral identiﬁcation of Nε-acetyllysine in acetylated human
αA-crystallin
In gel digestion was performed as described in Section 2.1, except
that 0.2 μg sequencing grade modiﬁed endopeptidase Asp-N (Reche
Diagnostics Corporation, Indianapolis, IN) was used instead of trypsin.
Other details are same as in Section 2.1.2.6. Determination of amino groups in acetylated αA-crystallin
The amino group content in the control and the acetylated αA-
crystallin was measured using ﬂuorescamine as previously described
[35].2.7. Chaperone assays
The chaperone assays were carried out as previously described [36].
The following ratios of αA-crystallin to client proteins (w/w) were
used: αA-crystallin:citrate synthase-1:14; αA-crystallin:βL-crystallin
— 1:30; αA-crystallin:γ-crystallin — 1:12; and αA-crystallin:lysozyme
— 1:4.Fig. 1. Mass spectrometric detection of Nε-acetyllysine at K70 in human lens αA-
crystallin. Tandem mass spectrum of DKFVIFLDVK of αA-crystallin with m/
z=633.3621(2+). The mass shift of 42.013 Da on the parent ion and b series ions sug-
gested acetylation of K70.2.8. Western blotting for Nε-acetyllysine in proteins
Proteins were separated on a 12% denaturing gel, transferred to ni-
trocellulose and probed with a monoclonal antibody to Nε-acetyllysine
(1:50,000 diluted) and an HRP-conjugated goat anti-mouse IgG
(1:5000 diluted). The immunoreactivitywas detected using a Pierce En-
hanced Chemiluminescence Detection Kit.2.9. Surface hydrophobicity and tryptophan ﬂuorescence
The surface hydrophobicity of the protein was measured using
TNS (emission: 350–520 nm, excitation: 320 nm) as previously de-
scribed [37]. Tryptophan ﬂuorescence of the protein was recorded
at emission wavelengths of 300–400 nm and an excitation wave-
length of 290 nm [38]. Protein samples (0.1 mg/ml) in 50 mM phos-
phate buffer, pH 7.2, were used in both of the experiments.
2.10. CD spectra of acetylated αA-crystallin
Far-UV CD spectra were measured at 25 °C using a Jasco 810
spectropolarimeter (Jasco, Inc., Japan). Spectra were collected from
250 to 200 nm using a cylindrical quartz cell with a 1.0 mm path
length. Proteins (0.2 mg/ml) were dissolved in 10 mM phosphate buff-
er, pH 7.2. The resultant spectra after ﬁve scans were analyzed for sec-
ondary structure by the CONTINLL curve-ﬁtting program [38].
Near-UV CD spectra were measured at 25 °C using the same spec-
tropolarimeter. Spectra were measured with 0.5 mg/ml protein solu-
tions in 50 mM phosphate buffer, pH 7.2. The reported spectra were
the average of 5 scans.
2.11. Multiangle light scattering studies
We analyzed Wt, K70Q and acetylated αA-crystallin (2 molar ex-
cess of Ac2O) by MLS conditions as previously described [39]. Brieﬂy,
the samples were incubated at 37 °C for 30 min before injecting
(75 μg) into a TSKG5000PWXL column connected to MLS detectors.
The data was analyzed using the ASTRA software (5.3.4.20) developed
by Wyatt Technology Corp., Santa Barbara, CA.
2.12. Structural stability of acetylated αA-crystallin
The effect of acetylation on the stability of wild-type αA-crystallin
was determined by an equilibrium chemical denaturation
Fig. 2. Effect of age on the Nε-acetyllysine content in human lens proteins. Human lens proteins were separated into water soluble (WS) and insoluble fractions by homogenization and
centrifugation. The water-insoluble fraction was sonicated and centrifuged to obtain a soluble fraction (SWI). The two fractions were tested in a direct ELISA for Nε-acetyllysine content.
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pH 7.5) was incubated with various urea concentrations (0–6 M) for
18 h at 25 °C. The tryptophan ﬂuorescence spectra of all samples
were recorded in the 300–400 nm region using an excitation wave-
length of 295 nm. The equilibrium unfolding proﬁle was ﬁtted
according to a three-state model [33].
3. Results
3.1. Nε-acetyllysine in human lens proteins
To determine the in vivo acetylation sites in human lens α-crystallin,
we used the SDS-PAGE protein band corresponding to α-crystallin from
a 59 year old normal lens. Mass spectrometric analyses indicated that
K70 and K99 are acetylated in αA-crystallin and K92 and K166 are acet-
ylated in αB-crystallin (Table 1). Fig. 1 shows an example of tandem
mass spectrum of an acetylated peptide. Comparing with unmodiﬁed
peptide DKFVIFLDVK of αA-crystallin, the mass shift of 42.013 Da was
observed on parent ion and through b2 to b9 ions, while all y2 to y8
ions remained unchanged. This strongly suggested that K70 was
acetylated.
The ELISA results showed that both theWS and SWI fractions react
with the Nε-acetyllysine antibody. We sought to determine the effect
of age on the total Nε-acetyllysine content in the lens. The results in-
dicated that a slow progressive accumulation of Nε-acetyllysine oc-
curs up to ~40 years in both the WS and SWI fractions, peakingFig. 3. Detection of Nε-acetyllysine in human lens proteins byWestern blotting. WS and SWI
to a nitrocellulose membrane and probed with a monoclonal antibody to Nε-acetyllysine (
below the lanes are the age of the lens.between 30 and 40 years and then gradually declining with age
(Fig. 2). The immunoreactivity was completely abolished by prior in-
cubation of the antibody with acetylated BSA, conﬁrming that the re-
action was speciﬁc for Nε-acetyllysine in αA-crystallin (data not
shown).
SDS-PAGE separation ofWS and SWI fractions are shown in Fig. 3A
and B. Western blotting showed multiple immunoreactive protein
bands both in WS and SWI fractions (Fig. 3C and D) with a strong re-
action in the 20–25 and 40–45 kDa regions. Some immunoreactivity
was also detected in highly cross-linked high molecular weight
proteins.
Next, we wanted to demonstrate by immunoprecipitation and
western blotting that αA-crystallin is acetylated in vivo. Our at-
tempts to immunoprecipitate lens proteins using either an antibody
for Nε-acetyllysine or an antibody to αA-crystallin failed because of
a non-speciﬁc interaction between α-crystallin with protein A/G
Sepharose. However, western blotting for αA-crystallin and Nε-
acetyllysine showed the same protein reacting with two antibodies
(Fig. 4), indicating that αA-crystallin is acetylated in human lens
proteins.
3.2. Acetylation of αA-crystallin
To determine the effect of acetylation on the chaperone function
of αA-crystallin, recombinant αA-crystallin was acetylated using
Ac2O. We used 2, 5, 10, 25 and 100 molar excesses of Ac2O versusfractions were subjected to SDS-PAGE (A and B) under reducing conditions, transferred
C and D). Representative lenses from every decade of life were chosen. The numbers
Fig. 4. Acetylation of αA-crystallin in the human lens. Water-soluble lens proteins were western blotted using an antibody for αA-crystallin (A) and for Nε-acetyllysine (B). The
arrow indicates the location of αA-crystallin. The numbers below the lanes indicate the age of the lens.
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for the acetylation studies. The amino group measurement using
ﬂuorescamine showed a progressive decline in the free amino group
content with increased concentrations of Ac2O (Fig. 5A). A two
molar excess of Ac2O reduced the free amino group by 25%, and a
100 molar excess reduced it by ~60%. SDS-PAGE proﬁle showed
some crosslinking in acetylated proteins (Fig. 5B). Western blotting
using an Nε-acetyllysine antibody showed a strong reaction with mo-
nomeric αA-crystallin (Fig. 5 C), and the intensity of the reaction in-
creased with increasing concentrations of acetic anhydride. It is
noteworthy that a 40-kDa protein, possibly arising from the cross-
linking of two αA-crystallin molecules, was present in all samples
treated with Ac2O. It is not clear how acetylation produced cross-
linked αA-crystallin. In addition, many high molecular weight cross-
linked proteins were also seen with acetylated αA-crystallin. The
ELISA results with three concentrations of protein (2, 5 and 10 ng/
well) used for coating the wells also showed a direct relationshipFig. 5. In vitro acetylation of αA-crystallin. Human αA-crystallin was incubated with acetic a
shown as control, αA(2), αA(5), αA(10), αA(25) and αA(100), respectively, in this and su
ﬂuorescamine (A). The SDS-PAGE proﬁle of acetylated αA-crystallin is shown in panel (B
against the Nε-acetyllysine antibody (C). The immunoreactivity increased with increasing c
protein also reacted. A direct ELISA was used to determine the Nε-acetyllysine content in
coated with 2, 5 or 10 ng of acetylated αA-crystallin in these assays. Other details of the ELbetween acetylation and the Nε-acetyllysine content αA-crystallin
(Fig. 5D).
Mass spectrometry of the acetylated sample (10 molar excess of
Ac2O) showed acetylation of all lysine residues (Table 2). However,
we have not determined the extent of the acetylation of individual ly-
sine residues.3.3. Chaperone function of acetylated αA-crystallin
The chaperone function of the acetylated protein was evaluated
using four different client proteins. With CS as the client protein,
the chaperone function of acetylated αA-crystallin increased by 20%
and 40% when acetylated with a 2 and 5 molar excess of Ac2O over
the control (unmodiﬁed αA-crystallin), respectively (Fig. 6A). Such
an increase in the chaperone function was also noted at lower de-
grees of acetylation with 0.01 and 0.05 molar excess of Ac2Onhydride (Ac2O) at lysine:Ac2O molar ratios of 1:0, 1:2, 1:5, 1:10, 1:25 or 1:100 and are
bsequent ﬁgures. The amino group content in the modiﬁed protein was assessed using
). Western blotting of the acetylated αA-crystallin showed strong immunoreactivity
oncentrations of acetic anhydride. In addition to the monomeric protein, cross-linked
acetylated αA-crystallin. M=molecular weight markers (D). The microplate well was
ISA have been described in Methods.
Table 2
Identiﬁcation of Nε-acetyllysine in acetylated αA-crystallin.
Peptides No. Obs. mass Acetylation sites
MDVTIQHPWFKRTLGPFYPSRLF 1–23 2893.4740 Protein N-term
2935.4845 Protein N-term, K11
DVTIQHPWFKRTLGPFYPSRLF 2–23 2746.4368 K11
DKFVIFL 69–75 922.5157 K70
DVKHFSPE 76–83 999.4656 K78
DVKHFSPEDLTVKVQ 76–90 1782.9132 K88
1824.9238 K78, K88
DLTVKVQ 84–90 843.4706 K88
DDFVEIHGKHNERQ 91–104 1764.8180 K99
DFVEIHGKHNERQ 92–104 1649.7907 K99
DGMLTFCGPKIQTGL 136–150 1678.8052 K145
DATHAERAIPVSREEKPTSAPSS 151–173 2477.2147 K166
αA-crystallin was acetylated with 10 molar excess of Ac2O (compared to the lysine
content).
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function was noticed with a higher Ac2O concentration (>10 molar
excess), but the improvement was still greater than with the unmodi-
ﬁed protein (10–20% higher). With βL-crystallin as the client protein,
the chaperone function progressively improvedwith increased concen-
trations of Ac2O (Fig. 6B) except for a 2 molar excess of Ac2O, where a
slight reduction was noticed. The improvement in the chaperone func-
tion reached 25% with a 100 molar excess of Ac2O. With γ-crystallin as
the client protein, at low concentrations of Ac2O (2–10 molar excess),
there was a decrease in chaperone function (Fig. 6 C). However, with
higher concentrations of Ac2O (>25 molar excess), there was a
50–60% increase in chaperone function. The three assays above are
based on the thermal aggregation of client proteins. To determine if
acetylation affected the chemical aggregation of proteins, we used lyso-
zyme as the client protein. The aggregation of lysozyme was induced
by DTT. Like CS, at low concentrations of Ac2O (b25 molar excess),
the chaperone function of αA-crystallin improved by 15–20% with
acetylation (Fig. 6D). However, at higher concentrations of Ac2O, the
chaperone function was similar to that of the unmodiﬁed protein.
Taken together, these data suggest that the acetylation of lysine resi-
dues in αA-crystallin alters its chaperone function and that there is aFig. 6. Effect of acetylation on the chaperone function of αA-crystallin. The chaperone func
(A) Citrate synthase (CS); (B) βL-crystallin; (C) γ-crystallin and (D) lysozyme. Assays werediscordant effect with regard to the client protein. The improved chap-
erone function at low concentrations of Ac2O (b10 molar excess) with
three out of the four client proteins tested suggests that acetylation
could be a protective mechanism to preserve the chaperone function.
3.4. Chaperone function of K70 acetylation mimic
Because it has been reported that K70 in αA-crystallin is the major
site of acetylation in the human lens [26], which is corroborated by our
mass spectrometry data, we generated an acetylation mimic at this site
by replacing lysine with glutamine (K70Q). Many studies have used
this strategy to study the effects of acetylation on speciﬁc lysine resi-
dues in proteins [7,40,41]. The K70Q was puriﬁed by the same proce-
dure as the Wt protein. SDS-PAGE showed a single protein band for
both proteins (Supplemental Data, Fig. 2S). The chaperone function of
the mutant protein was compared with the Wt protein using the
same four client proteins that were used to test the effect of acetylation
on the chaperone function and adhering to the same ratios between
αΑ-crystallin and the client proteins. With CS, βL-crystallin and lyso-
zyme, the mutant protein showed 26, 15 and 5% increases in the chap-
erone function compared to theWt protein, respectively (Fig. 7A, B and
D). However, with γ-crystallin as the client protein, the mutant pro-
tein's chaperone functionwas reduced by 30% compared to theWt pro-
tein (Fig. 7C), which was similar to the mildly acetylated protein
(Fig. 6C). Taken together, similar to acetylated protein, the acetylation
mimic in general showed an increase in the chaperone function.
3.5. Tryptophan ﬂuorescence
Tryptophan ﬂuorescence of the acetylated proteins was in general
increased, although there was no strict relationship between trypto-
phan ﬂuorescence and the extent of acetylation (Fig. 8A). Proteins
modiﬁed with 25 and 100 molar excesses of Ac2O showed the highest
ﬂuorescence, which was two times that of the unmodiﬁed protein at
the excitation maximum of 340 nm. αA-crystallin has one tryptophan
residue per molecule. The increased tryptophan ﬂuorescence indicat-
ed that as a result of acetylation, the protein's tertiary structure wastion of αA-crystallin was assessed using four client proteins, as described in Methods.
done in triplicate and the bars represent the mean±SD.
Fig. 7. Effect of the introduction of an acetylation mimic at K70 on the chaperone function of αA-crystallin. The K70 residue in αA-crystallin was replaced with glutamine (K70Q) to
mimic acetylation. The chaperone function was evaluated using four client proteins. (A) Citrate synthase (CS); (B) βL-crystallin; (C) γ-crystallin and (D) lysozyme. Assays were
done in triplicate and the bars represent the mean±SD.
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slightly reduced in the K70Q mutant protein when compared to the
Wt protein (Fig. 8B), indicating that acetylation at K70 mildly alters
the tertiary structure of the protein.3.6. Surface hydrophobicity
We found the surface hydrophobicity of the protein increased
with acetylation; the increase was directly proportional to the extent
of acetylation (Fig. 8 C) except for the protein modiﬁed with a 2molar
excess of Ac2O, which was more hydrophobic than the protein mod-
iﬁed with a 5 molar excess of Ac2O. The increase in surfaceFig. 8. Effect of acetylation on tryptophan ﬂuorescence and surface hydrophobicity in αA-cr
and emission wavelengths of 300–400 nm for in vitro acetylated αA-crystallin (A) and the
mutant protein (D) was assessed using TNS. TNS ﬂuorescence was recorded at an excitatiohydrophobicity was almost 2-fold higher in the protein modiﬁed
with a 100 molar excess of Ac2O compared to the unmodiﬁed protein.
The surface hydrophobicity of the K70Q mutant protein was nearly
half that of the Wt protein (Fig. 8D), which suggested that the in-
creased chaperone function of the mutant protein was unrelated to
the surface hydrophobicity.3.7. Multi-angle light scattering analysis
We found that the average molar mass of Wt and K70Q to be com-
parable and they were, 1.325±0.012e+6 g/mol and 1.308±
0.014e+6 g/mol respectively. However, the average molar mass forystallin. Tryptophan ﬂuorescence was recorded at an excitation wavelength of 290 nm
acetylation mimic (B). The surface hydrophobicity of the acetylated (C) and the K70Q
n wavelength of 320 nm and emission wavelengths 350–520 nm.
Fig. 9. Effect of acetylation on the secondary and tertiary structure of αA-crystallin. The secondary structure of the acetylated (A) and K70Q mutant (B) was assessed by far-UV CD
spectroscopy, and the tertiary structure of the acetylated (C) and K70Q mutant protein (D) was assessed by near-UV CD spectroscopy.
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1.068±0.010e+6 g/mol. The chromatograms are shown in Supple-
mental Fig. 3S.
3.8. UV-CD spectroscopy
Far-UV CD spectra indicated that in vitro acetylation of αA-
crystallin perturbed its secondary structure (Fig. 9A). We found that
unmodiﬁed/wild-type αA-crystallin is a major β-sheet protein
(39.2% β-sheet and only 6% α-helix). We also found that the extent
of the increase in β-sheet content (39.2%–51%) with Ac2O treatmentFig. 10. Effect of acetylation on the equilibrium urea unfolding proﬁle of αA-crystallin. Pr
0–6 M urea at 25 °C. The equilibrium urea unfolding proﬁles of acetylated (A) and K70Q (B
per the three state model. The magnitudes of C1/2 and ΔG0 have also been plotted for acetydirectly related to the degree of acetylation modiﬁcation in αA-
crystallin: the higher the Ac2O concentration, the greater the pertur-
bation in the secondary structure of αA-crystallin. However, the
K70Q mutant had little effect on the secondary structural packing of
αA-crystallin (Fig. 9B).
Near-UV CD data (Fig. 9C–D) supports our intrinsic tryptophan
ﬂuorescence results (Fig. 8). The signal for phenylalanine
(250–270 nm region) was considerably altered in the acetylated
and K70Q proteins compared to the Wt protein. Moreover, peaks be-
yond 270 nm for the acetylated and K70Q proteins were also found to
differ both in intensity and in position from those of the Wt protein.oteins (0.05 mg/ml) were suspended in 50 mM phosphate buffer (pH 7.2) containing
) αA-crystallin have been normalized to a scale of 0–1. The values were calculated as
lated (C) and K70Q (D) αA-crystallin.
Table 3
C1/2 and ΔG0 values of acetylated and K70Q αA-crystallin at 25 °C.
Sample C1/2 (M) ΔG0 (kcal/mole)
Unacetylated/control 2.34 11.89±0.7a
αA(2) 2.34 11.06±0.6
αA(5) 2.18 7.06±1.2
αA(10) 1.73 5.44±0.9
αA(25) 2.16 8.61±1.1
αA(100) 2.05 6.35±0.5
K70Q 2.61 12.62±0.8
a Mean±SD.
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proteins suggest that the microenvironments of the amino acid resi-
dues (Phe, Tyr and Trp) were signiﬁcantly perturbed by acetylation.
3.9. Thermodynamic stability of acetylated αA-crystallin
We compared the thermodynamic stability of acetylated and mu-
tant proteins by equilibrium urea unfolding measurements. Trypto-
phan ﬂuorescence intensities were recorded at 337 and 350 nm at
various urea concentrations. The data were plotted as the ratio of
the intensities at 337 and 350 nm as a function of the urea concentra-
tion (Fig. 10). A crude estimate of the transition midpoint (C1/2) from
a sigmoidal analysis of the denaturation proﬁles revealed that the C1/2
value decreased from 2.34 M for the wild-type/unmodiﬁed control
protein to 1.7 M urea for the acetylated αA-crystallin (Fig. 10A,
Table 3). This decreasing trend in the C1/2 values clearly indicated
that acetylation destabilized the oligomeric assembly of αA-
crystallin. On the other hand, the transition midpoint (C1/2) value in-
creased slightly in the K70Q mutant (Fig. 10B; Table 3). To quantify
the stability against chemical denaturation, all of the proﬁles were an-
alyzed by a global three-state ﬁtting procedure, according to the
equation:
F ¼
F0 þ F1⋅exp −ΔG01 þm1⋅ urea½ 
 
=RT þ F∞⋅exp −ΔG02 þm2 urea½ 
 
=RT
1þ exp −ΔG01 þm1⋅ urea½ 
 
=RT þ exp −ΔG02 þm2⋅ urea½ 
 
=RT
where F0, F1 and F∞ are the signal intensities for the 100% native, 100%
intermediate and 100% unfolded form, respectively. ΔG10 refers to the
standard free energy change between the native and the intermediate
form, and ΔG20 refers to the standard free energy change between the
intermediate and unfolded form. ΔG0, being the sum of ΔG10 and ΔG20,
refers to the standard free energy change of unfolding (between the
native and unfolded form) at a zero urea concentration. The standard
free energy change (N→U) of the unfolding of the wild-type αA-
crystallin, obtained according to a three-state model, was
11.89 kcal/mol (Table 3). This standard free energy change magni-
tude decreased gradually upon treatment with higher concentrations
of Ac2O. On the other hand, the K70Q mutant had very minute effect
on the structural stability of human αA-crystallin.
4. Discussion
The present study was conducted in light of the discoveries in Jean
Smith's laboratory that α-crystallin is acetylated in vivo [26,27]. The
availability of a monoclonal antibody against Nε-acetyllysine allowed us
to develop an ELISA to determine the effect of aging on the Nε-acetylly-
sine content in the human lens. Acetylated lysine residues were observed
in both the WS and SWI fractions. We found that the acetylation of lens
proteins occurs very early in age and stays somewhat constant through-
out life, with the exception of a peak in Nε-acetyllysine content between
ages 30–40 in several lenses in both theWS and SWI fractions. The trend
toward a decrease in Nε-acetyllysine content after ~40 years of age could
be due to masking of the antigen in proteins because of increased age-
associated crosslinking and aggregation.Jean Smith's laboratory also reported that nearly 5% of the αA-
crystallin in the human lens is acetylated at K70 [26]. The present
study conﬁrmed that acetylation can occur at this lysine residue.
The immediate question was: how does acetylation affect the func-
tion of αA-crystallin? One major function of αA-crystallin is its ability
to chaperone structurally perturbed proteins and prevent their dena-
turation [11]. Because lens proteins have a negligible turnover rate
during life, they can accumulate post-synthetic modiﬁcations during
aging. Such modiﬁcations could result in lens protein aggregation
and lead to cataract formation. The chaperone function of α-
crystallin has been perceived to be important for preventing such
protein aggregation and to maintain lens transparency during aging.
Our study showed that at low levels of acetylation, αA-crystallin's
chaperone function is generally increased. However, not all client pro-
teins behaved the same way; for example, with γ-crystallin as the cli-
ent protein, there was a loss of chaperone function with low levels of
acetylation. This suggests the possibility that not all client proteins
bind to the same chaperoning site in αA-crystallin, which has been
previously proposed [42,43]. Some chaperone sites may be negatively
affected and others may be positively affected by acetylation. Similar
observations were made with the K70Q mutant acetylation mimic. It
showed better chaperone function against CS, βL-crystallin and lyso-
zyme but showedweaker chaperone function against γ-crystallin com-
pared to the Wt protein, reiterating the notion that the chaperone sites
for client proteins could be different in αA-crystallin. Whether or not
the altered chaperone function ofαA-crystallin from acetylation results
in increased interactions with client proteins and consequently their
ubiquitination and degradation, akin to Hsp70, needs to be veriﬁed
[44]. Similarly, whether acetylation ofαA-crystallin is beneﬁcial or det-
rimental to the lens is not clear, because of the discordant effects on the
aggregation of γ- and βL-crystallins.
Acetylation increased the intensity of tryptophan ﬂuorescence,
suggesting a structural perturbation leading to protein unfolding
and the exposure of the buried tryptophan to the surface in αA-
crystallin. Such unfolding of the protein by acetylation could have
led to higher surface hydrophobicity, as measured by TNS binding.
Whether or not higher surface hydrophobicity was the reason for
the higher chaperone function was not clear, but it seems unlikely
given the reduced chaperone function against γ-crystallin when the
surface hydrophobicity was already increased. Previous studies also
have observed that there is no strict relationship between surface hy-
drophobicity and the chaperone function in α-crystallin [45,46]. Sup-
porting this argument is another observation from this study that the
K70Q mutant protein, which displayed higher chaperone function
against three of the four client proteins, had lower surface hydropho-
bicity than the Wt protein.
Most small heat shock proteins exist in oligomeric forms. Whether
oligomerization is a pre-requisite for their chaperone function is de-
bated. Saha and Das [47] demonstrated that the chaperone activity
of human αA- and αB-crystallin depends more on the alpha-
crystallin domain and hydrophobic clefts on the protein surface
than on their oligomeric size. However, Gu et al. [48] reported that
dissociation of the oligomeric structure is essential for the
chaperone-like activity of Hsp16.3. In this study, we found that acet-
ylation with Ac2O improved the chaperone function of αA-crystallin
despite the fact that the overall structural integrity/assembly of the
protein was destabilized. Exactly how acetylation improves the chap-
erone function is not known. The data from the MLS analyses that
acetylated protein has lower molar mass when compared to the
unmodiﬁed protein hints to the possibility that acetylation resulted
in partial dissociation of the oligomeric protein and led improvement
in the chaperone function. A similar improvement in the chaperone
function as a result of a reduction in oligomeric size has been previ-
ously observed for αB-crystallin [39].
In summary, the present study showed that the acetylation of αA-
crystallin occurs in the human lens. Whether the acetylation of αA-
129R.H. Nagaraj et al. / Biochimica et Biophysica Acta 1822 (2012) 120–129crystallin increases the binding and disposal of damaged proteins
through ubiquitination is to be determined. Acetylation could also be
a strategy to limit other modiﬁcations of lysine residues in proteins.
Supplementary materials related to this article can be found on-
line at doi:10.1016/j.bbadis.2011.11.011.
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